Jianbing Wu

1.1k total citations
55 papers, 889 citations indexed

About

Jianbing Wu is a scholar working on Molecular Biology, Organic Chemistry and Neurology. According to data from OpenAlex, Jianbing Wu has authored 55 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 12 papers in Organic Chemistry and 10 papers in Neurology. Recurrent topics in Jianbing Wu's work include Nitric Oxide and Endothelin Effects (8 papers), Nanoplatforms for cancer theranostics (8 papers) and Neurological Disease Mechanisms and Treatments (8 papers). Jianbing Wu is often cited by papers focused on Nitric Oxide and Endothelin Effects (8 papers), Nanoplatforms for cancer theranostics (8 papers) and Neurological Disease Mechanisms and Treatments (8 papers). Jianbing Wu collaborates with scholars based in China, United States and Macao. Jianbing Wu's co-authors include Zhangjian Huang, Yihua Zhang, H. An, Dachuan Lin, Michael T. Morrissey, Tian Lv, Yue Fei, Zhuangzhuang Liang, Jian Jia and Fenghua Kang and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Communications and Small.

In The Last Decade

Jianbing Wu

48 papers receiving 861 citations

Peers

Jianbing Wu
R. Natesh United Kingdom
Peng Yang China
Bei Tong China
Xinzhi Li China
Junsoo Park South Korea
Jianbing Wu
Citations per year, relative to Jianbing Wu Jianbing Wu (= 1×) peers Haiying Cai

Countries citing papers authored by Jianbing Wu

Since Specialization
Citations

This map shows the geographic impact of Jianbing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianbing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianbing Wu more than expected).

Fields of papers citing papers by Jianbing Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianbing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianbing Wu. The network helps show where Jianbing Wu may publish in the future.

Co-authorship network of co-authors of Jianbing Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jianbing Wu. A scholar is included among the top collaborators of Jianbing Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianbing Wu. Jianbing Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeng, Jiayu, et al.. (2025). The role of ubiquitination and deubiquitination in cancer lipid metabolism. Frontiers in Oncology. 15. 1464914–1464914. 1 indexed citations
2.
Yu, Jun, et al.. (2025). A Fluorescent Probe for Imaging and Treating S-Nitrosation Stress in OGD/R Cells. Antioxidants. 14(3). 311–311. 1 indexed citations
3.
Lin, Jingjing, Xinyu Wu, Li Zuo, et al.. (2025). Deep Red‐Light‐Mediated Nitric Oxide and Photodynamic Synergistic Antibacterial Therapy for the Treatment of Drug‐Resistant Bacterial Infections. Small. 21(6). e2408759–e2408759. 8 indexed citations
4.
Qiao, Xinhua, Hui Ye, Xiaoli Cui, et al.. (2025). S-nitros(yl)ation of CaMKIIα and its precision redox regulation by SNOTAC plays a critical role in learning and memory. Redox Biology. 86. 103784–103784.
5.
Zhang, Honghua, et al.. (2025). Ischemic stroke and intervention strategies based on the timeline of stroke progression: Review and prospects. Acta Pharmaceutica Sinica B. 15(9). 4543–4581.
6.
Gu, Yuting, et al.. (2025). Therapeutic Targeting of PPARγ in Nonalcoholic Fatty Liver Disease: Efficacy, Safety, and Drug Development. Drug Design Development and Therapy. Volume 19. 7293–7319. 1 indexed citations
7.
Shi, Ying, Jieqiong Zhou, Lihua Liu, et al.. (2025). Targeting RNA binding proteins with small-molecule inhibitors: Advances, challenges, and therapeutic opportunities. Acta Pharmaceutica Sinica B. 16(3). 1292–1335.
9.
Lin, Jingjing, Yuxin Wang, Yue Xu, et al.. (2024). Photoresponsive nitric oxide photocage/photodynamic integrated prodrug for advanced management of drug-resistant bacteria-infected wound therapy. Bioorganic Chemistry. 154. 108062–108062.
10.
Chen, Bei, Jianbing Wu, Hongmei Wu, et al.. (2023). 1,3-Substituted β-Carboline Derivatives as Potent Chemotherapy for the Treatment of Cystic Echinococcosis. Journal of Medicinal Chemistry. 66(24). 16680–16693. 7 indexed citations
11.
Wang, Fangfang, Jianbing Wu, Xin Liu, et al.. (2023). Novel Nitric Oxide Donor–Azole Conjugation Strategy for Efficient Treatment of Cryptococcus neoformans Infections. Journal of Medicinal Chemistry. 66(20). 14221–14240. 5 indexed citations
12.
Wu, Jianbing, et al.. (2023). Advances in nitric oxide regulators for the treatment of ischemic stroke. European Journal of Medicinal Chemistry. 262. 115912–115912. 15 indexed citations
14.
Guan, Xin‐Yuan, Jianbing Wu, Jiahui Geng, et al.. (2022). A Novel Hybrid of Telmisartan and Borneol Ameliorates Neuroinflammation and White Matter Injury in Ischemic Stroke Through ATF3/CH25H Axis. Translational Stroke Research. 15(1). 195–218. 13 indexed citations
15.
Liu, Ping, Wen Huang, Jianbing Wu, et al.. (2021). Fasudil Dichloroacetate Alleviates SU5416/Hypoxia-Induced Pulmonary Arterial Hypertension by Ameliorating Dysfunction of Pulmonary Arterial Smooth Muscle Cells. Drug Design Development and Therapy. Volume 15. 1653–1666. 19 indexed citations
16.
Wu, Jianbing, Wei Yin, Zhangjian Huang, et al.. (2021). Design, Synthesis, and Biological Evaluation of Organic Nitrite (NO2) Donors as Potential Anticerebral Ischemia Agents. Journal of Medicinal Chemistry. 64(15). 10919–10933. 11 indexed citations
17.
Wu, Jianbing, Chenxi Yang, Tian Lv, et al.. (2020). Tetrazine-mediated bioorthogonal removal of 3-isocyanopropyl groups enables the controlled release of nitric oxide in vivo. Biomaterials Science. 9(5). 1816–1825. 9 indexed citations
18.
Wu, Jianbing, Wei Yin, Yinqiu Zhang, et al.. (2020). Design and synthesis of the ring-opened derivative of 3-n-butylphthalide-ferulic acid-glucose trihybrids as potential anti-ischemic agents. Chinese Chemical Letters. 31(7). 1881–1886. 13 indexed citations
19.
Huang, Zhangjian, Jianbing Wu, Yu Zou, et al.. (2018). Glutathione S-Transferase π-Activatable O2-(Sulfonylethyl Derived) Diazeniumdiolates Potently Suppress Melanoma in Vitro and in Vivo. Journal of Medicinal Chemistry. 61(5). 1833–1844. 17 indexed citations
20.
Loera, Jesús A. De, et al.. (2012). Software for exact integration of polynomials over polyhedra. Computational Geometry. 46(3). 232–252. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026